Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016
{{output}}
Developments in early breast cancer presented at the 2016 San Antonio Breast Cancer Symposium included important studies on extending adjuvant endocrine therapy with aromatase inhibitors, the role of bisphosphonates, and evidence for molecular prognostic facto... ...
